Fresenius Medical Care AG (XSWX:FME) Cyclically Adjusted Revenue per Share: CHF65.08 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:FME Fresenius Medical Care AG XSWX:FME
75 GF Score
Price CHF39.25
GF Value CHF37.64
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Cyclically Adjusted Revenue per Share?

Fresenius Medical Care AG XSWX:FME +0.44% 75 Cyclically Adjusted Revenue per Share is CHF65.08 as of Mar. 2026. GuruFocus rates XSWX:FME with a GF Score™ of 75/100 and a GF Value™ of CHF37.64. The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Fresenius Medical Care AG's adjusted revenue per share for the three months ended in Mar. 2026 was CHF15.251. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is CHF65.08 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Fresenius Medical Care AG's average Cyclically Adjusted Revenue Growth Rate was 2.80% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 4.70% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 7.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Fresenius Medical Care AG was 10.00% per year. The lowest was 3.50% per year. And the median was 7.50% per year.

As of today (2026-07-25), Fresenius Medical Care AG's current stock price is CHF39.25. Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was CHF65.08. Fresenius Medical Care AG's Cyclically Adjusted PS Ratio of today is 0.60.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius Medical Care AG was 2.41. The lowest was 0.43. And the median was 1.23.


Fresenius Medical Care AG  (XSWX:FME) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius Medical Care AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=39.25/65.08
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Fresenius Medical Care AG was 2.41. The lowest was 0.43. And the median was 1.23.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Related Terms


Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Chart

Fresenius Medical Care AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fresenius Medical Care AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 65.08

XSWX:FME vs HCA, THC, DVA: Cyclically Adjusted Revenue per Share Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius Medical Care AG Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Cyclically Adjusted PS Ratio falls into.


XSWX:FME
75GF Score
Fresenius Medical Care AG XSWX:FME
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius Medical Care AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Fresenius Medical Care AG's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=15.251/131.2583*131.2583
=15.251

Current CPI (Mar. 2026) = 131.2583.

Fresenius Medical Care AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 14.353 100.717 18.705
201609 15.035 101.017 19.536
201612 15.430 101.217 20.010
201703 15.808 101.417 20.459
201706 15.748 102.117 20.242
201709 16.224 102.717 20.732
201712 16.621 102.617 21.260
201803 15.165 102.917 19.341
201806 15.836 104.017 19.983
201809 14.959 104.718 18.750
201812 15.811 104.217 19.913
201903 15.235 104.217 19.188
201906 15.985 105.718 19.847
201909 15.993 106.018 19.801
201912 16.708 105.818 20.725
202003 15.960 105.718 19.816
202006 16.678 106.618 20.532
202009 16.230 105.818 20.132
202012 16.239 105.518 20.200
202103 15.905 107.518 19.417
202106 16.131 108.486 19.517
202109 16.449 109.435 19.729
202112 16.505 110.384 19.626
202203 15.885 113.968 18.295
202206 16.641 115.760 18.869
202209 16.737 118.818 18.489
202212 16.806 119.345 18.484
202303 15.887 122.402 17.036
202306 16.042 123.140 17.100
202309 16.152 124.195 17.071
202312 16.032 123.773 17.002
202403 15.552 125.038 16.326
202406 15.629 125.882 16.297
202409 15.255 126.198 15.867
202412 16.179 127.041 16.716
202503 15.892 127.779 16.325
202506 15.318 128.412 15.658
202509 15.626 129.255 15.868
202512 16.549 129.361 16.792
202603 15.251 131.258 15.251

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of CHF65.08 mean?
Fresenius Medical Care AG (XSWX:FME) has a Cyclically Adjusted Revenue per Share of CHF65.08 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius Medical Care AG and its competitors.
Is Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share too high?
Fresenius Medical Care AG's current Cyclically Adjusted Revenue per Share is CHF65.08. Overall, Fresenius Medical Care AG has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share compare to HCA and THC?
Fresenius Medical Care AG's Cyclically Adjusted Revenue per Share of CHF65.08 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Cyclically Adjusted Revenue per Share is CHF65.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Fresenius Medical Care AG (XSWX:FME) has a current Cyclically Adjusted Revenue per Share of CHF65.08. The stock's GF Value™ is CHF37.64, compared to a current price of CHF39.25 — trading 4.3% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is CHF65.08. Fresenius Medical Care AG's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Fresenius Medical Care AG (XSWX:FME), the current Cyclically Adjusted Revenue per Share is CHF65.08 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (XSWX:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued. The current stock price of CHF39.25 is trading 4.3% above its estimated GF Value™ of CHF37.64.

Key valuation signals for XSWX:FME:

  • Cyclically Adjusted Revenue per Share: CHF65.08
  • GF Value™: CHF37.64 vs. price of CHF39.25 (4.3% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the XSWX:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
75GF Score

Get the complete analysis for XSWX:FME

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF39.25
Price
CHF37.64
GF Value